Skip to main content

Advertisement

Table 1 Characteristics of newly diagnosed leukemic patients

From: Induction of anti-leukemic responses by stimulation of leukemic CD3+ cells with allogeneic stimulator cells

Pt# Sex Age Diagnosis WBC ALC Peripheral blasts (%) Cytogenetics molecular markers
1 Female 74 AML 17.1 6.2 6 XX
2 Female 65 AML 7.4 3.6 9 t (4;11), Tetrasomy 8
3 Male 26 CML 336.5 20.2 4 t (9;22)
4 Male 31 AML 9.2 2.7 39 inv (3), Monosomy 7
5 Female 86 AML 54.4 8.2 32 Trisomy 13
6 Male 32 AML 7.1 0.9 12 del (17), t (16;21)
7 Male 84 CMML 39.6 2.4 11 XY
8 Male 62 AML 19.4 2.5 23 inv (16), del (7)
9 Female 29 AML 8.6 4 47 t (11;20), FLT3 ITD+
10 Male 64 AML 138.3 16.6 80 XY, FLT3 ITD+
11 Female 70 AML 12.8 2.4 33 t (11;19)
12 Male 56 CMML 14.4 2.2 14 XY
13 Female 48 CMML 16.3 2.6 19 XX
14 Male 59 ALL 5.1 2.7 45 t (9;22)
15 Female 34 ALL 341.8 23.9 88 XX
16 Male 46 AML 18.5 2.3 73 t (15;17)
17 Male 64 AML 1.2 0.2 3 XY, FLT3 ITD+
18 Female 57 AML 34.5 1.7 9 XX inv (16)
19 Female 32 ALL 58.1 7.3 86 XX Ph+
20 Male 62 AML 28.1 8 9 XY
21 Female 77 AML 84.4 4.2 81 Not sent